Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma-Reference-Cited by-同舟云学术

Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma

Published:2016-04 Issue:2 Volume:373 Page:234-240
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Li Liang,Chen Jianguo,Chen Xin,Tang Jing,Guo Huan,Wang Xiaofeng,Qian Ji,Luo Guijuan,He Fangping,Lu Xiaomei,Ding Yibo,Yang Yingchen,Huang Wentao,Hou Guojun,Lin Ximeng,Ouyang Qin,Li Hengyu,Wang Ruoyu,Jiang Feng,Pu Rui,Lu Jianhua,Jin Mudan,Tan Yexiong,Gonzalez Frank J.,Cao Guangwen,Wu Mengchao,Wen Hao,Wu Tangchun,Jin Li,Chen Lei,Wang Hongyang

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin,2015

2. Design and endpoints of clinical trials in hepatocellular carcinoma;Llovet;J. Natl Cancer Inst,2008

3. Management of hepatocellular carcinoma;Bruix;Hepatology,2005

4. Gp73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma;Marrero;J. Hepatol,2005

5. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009;Poon;Lancet Oncol,2009

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. circ_HMGCS1 modulates hepatocellular carcinoma chemoresistance via miR‐338‐5p/IL‐7 pathway;Journal of Cellular and Molecular Medicine;2024-03

2. Multidimensional regulatory networks of noncoding RNAs and hepatocellular carcinoma;SCIENTIA SINICA Vitae;2023-11-01

3. N6-methyladenosine modification promotes hepatocarcinogenesis through circ-CDYL-enriched and EpCAM-positive liver tumor-initiating exosomes;iScience;2023-10

4. Dual mechanism of Let-7i in tumor progression;Frontiers in Oncology;2023-09-27

5. Development and validation of a circulating serum-based six- microRNA signature for predicting hepatocellular carcinoma;2023-06-14